Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ganciclovir Patent Expiration

Ganciclovir was first introduced by Roche Palo Alto Llc in its drug Cytovene on Dec 22, 1994. Other drugs containing Ganciclovir are Vitrasert, Zirgan, Ganzyk-Rtu. 4 different companies have introduced drugs containing Ganciclovir.


Ganciclovir Patents

Given below is the list of patents protecting Ganciclovir, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Ganzyk-rtu US9486530 Ganciclovir compositions and related methods Sep 02, 2034 Exela Pharma



Ganciclovir's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ganciclovir Generic API Manufacturers

Several generic applications have been filed for Ganciclovir.

Given below is the list of companies who have filed for Ganciclovir generic, along with the locations of their manufacturing plants worldwide.


1. RANBAXY LABS LTD

Ranbaxy Laboratories Ltd has filed for 2 different strengths of generic version for Ganciclovir. Given below are the details of the strengths of this generic introduced by Ranbaxy Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG

capsule Discontinued ORAL N/A Jun 27, 2003
250MG

capsule Discontinued ORAL N/A Jun 27, 2003